Last reviewed · How we verify
Sodium Fluoride F-18 Injection
Sodium Fluoride F-18 Injection is a radiopharmaceutical used for diagnostic imaging.
Sodium Fluoride F-18 Injection is a radiopharmaceutical used for diagnostic imaging. Used for Detection and monitoring of bone metastases, Assessment of bone health in patients with cancer.
At a glance
| Generic name | Sodium Fluoride F-18 Injection |
|---|---|
| Also known as | 18F-NaF Injection |
| Sponsor | HTA Co., Ltd. |
| Drug class | Radiopharmaceutical |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
It works by emitting positrons that allow for the visualization of bone structures, particularly useful in detecting and monitoring bone metastases and other bone-related conditions.
Approved indications
- Detection and monitoring of bone metastases
- Assessment of bone health in patients with cancer
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Fatigue
Key clinical trials
- Imaging in MGUS, SMM and MM (PHASE2)
- PET/CT Guided Robotic Arm-assisted Pain Palliation in Chronic Nociceptive Low Backache (NA)
- Effect of Evolocumab on Coronary Atherosclerosis (PHASE3)
- Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients
- Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT (PHASE3)
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium Fluoride F-18 Injection CI brief — competitive landscape report
- Sodium Fluoride F-18 Injection updates RSS · CI watch RSS
- HTA Co., Ltd. portfolio CI